These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 37881126)
1. METTL3 promotes choriocarcinoma progression by activating the miR-935/GJA1 pathway in an m6A-dependent manner. Wang W; Shi J; Zheng L Am J Reprod Immunol; 2023 Nov; 90(5):e13791. PubMed ID: 37881126 [TBL] [Abstract][Full Text] [Related]
2. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway. Ye K; Li L; Wu B; Wang D Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324 [TBL] [Abstract][Full Text] [Related]
3. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression. Li S; Lu X; Zheng D; Chen W; Li Y; Li F J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010 [TBL] [Abstract][Full Text] [Related]
4. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner. Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135 [TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP. Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729 [TBL] [Abstract][Full Text] [Related]
6. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A. Huang Y; Guan Y; Zhang X Mol Biotechnol; 2024 Aug; 66(8):1942-1953. PubMed ID: 37498409 [TBL] [Abstract][Full Text] [Related]
7. METTL3-mediated m6A modification promotes processing and maturation of Gong Y; Jiang Q; Liu L; Liao Q; Yu J; Xiang Z; Luo X Physiol Genomics; 2022 Sep; 54(9):337-349. PubMed ID: 35759451 [TBL] [Abstract][Full Text] [Related]
8. m6A-modified circ_0124554 promotes colorectal cancer progression and radioresistance through the miR-1184/LASP1 pathway. Zhong X; Peng Y; Zhang X; Peng L; Ma K; Huang Y; Yang X Pathol Res Pract; 2024 Jan; 253():154950. PubMed ID: 38091882 [TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1. Bao J; Xu T; Wang W; Xu H; Chen X; Xia R Mol Cell Biochem; 2024 Nov; 479(11):3077-3089. PubMed ID: 38180718 [TBL] [Abstract][Full Text] [Related]
10. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940 [TBL] [Abstract][Full Text] [Related]
11. METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b. Huang L; Liang D; Zhang Y; Chen X; Chen J; Wen C; Liu H; Yang X; Yang X; Lin S J Cancer Res Clin Oncol; 2023 Jul; 149(8):5095-5108. PubMed ID: 36348020 [TBL] [Abstract][Full Text] [Related]
13. METTL3 and IGF2BP1-Mediated m6A Modification of ZHX2 Promotes Tumor Property of Renal Cell Carcinoma. Xiao B; Li Y; Yang Y; Chen C; Gong S; Li H; Yao Q; Wang L Kidney Blood Press Res; 2024; 49(1):787-798. PubMed ID: 39159608 [TBL] [Abstract][Full Text] [Related]
14. METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth. Wu S; Wang H; Yang Q; Liu Z; Du J; Wang L; Chen S; Lu Q; Yang DH Cancer Lett; 2024 Aug; 597():217058. PubMed ID: 38880226 [TBL] [Abstract][Full Text] [Related]
15. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway. Peng W; Li J; Chen R; Gu Q; Yang P; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y J Exp Clin Cancer Res; 2019 Sep; 38(1):393. PubMed ID: 31492150 [TBL] [Abstract][Full Text] [Related]
16. METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer. Liu J; Jiang K J Cell Mol Med; 2022 May; 26(9):2505-2519. PubMed ID: 35348293 [TBL] [Abstract][Full Text] [Related]
17. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related]
18. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression. Hua M; Zhai X; Chen Y; Yin D Pathol Res Pract; 2024 Aug; 260():155437. PubMed ID: 38959625 [TBL] [Abstract][Full Text] [Related]
19. m Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312 [TBL] [Abstract][Full Text] [Related]
20. METTL3 is aberrantly expressed in endometriosis and suppresses proliferation, invasion, and migration of endometrial stromal cells. Zhang QC Kaohsiung J Med Sci; 2023 Mar; 39(3):266-277. PubMed ID: 36546578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]